TIS tissue therapies limited

the report is out

  1. 1,992 Posts.
    lightbulb Created with Sketch. 104
    ASCI believes TIS is the most exciting and risky stock in their portfolio and a great opportunity that could produce triple digit percentage gains.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.